Monza, Italy

Gaetano Battelli

This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaetano Battelli. Retrieved from https://idiyas.com/inventor/gaetano-battelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaetano Battelli and a Cisplatin Formulation Patent.

Introduction

Gaetano Battelli is an inventor associated with Monza, Italy, and Farmitalia Carlo Erba. His patent work concerns a pharmaceutical formulation intended to improve the preparation and therapeutic use of cisplatin, an antitumor drug.

Latest Patents

Battelli is credited with 1 patent: “Novel Pharmacological Compositions Based on Cisplatinum and Method for…” The invention describes sterile, stable, freeze-dried cisplatin formulations containing 10 to 50 milligrams of active ingredient. The formulations are designed to dissolve rapidly and conveniently for intravenous administration in antitumor chemotherapy.

The patent describes using specific formulation conditions, including solution concentration, alcohols, and pH adjustment, followed by freeze-drying in a water-alcohol medium. According to the supplied description, this approach addresses manufacturing difficulties associated with freeze-drying cisplatin in water, including container breakage and low yields, while offering an economically advantageous process.

Career Highlights

Battelli’s documented patent contribution focuses on pharmaceutical formulation and manufacturing. The invention aims to produce cisplatin preparations that are practical to manufacture at industrial scale and suitable for therapeutic use.

Collaborations

Battelli’s listed coworkers include Diego Oldani and Alessandro Rigamonti. The patent is associated with Farmitalia Carlo Erba.

Conclusion

Gaetano Battelli’s patent describes a manufacturing approach for stable, rapidly dissolving cisplatin formulations, addressing production challenges and supporting their use in intravenous antitumor chemotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…